Controlled and uncontrolled allergic asthma in routine respiratory specialist care a clinicalepidemiological study in Germany

Current Medical Research and Opinion

Volumn 27, Issue 9, 2011, Pages 1835-1847

  Kardos, P ^a   Wittchen, H U ^b   Mhlig, S ^c   Ritz, T ^d   Buhl, R ^e   Rabe, K ^f,g   Klotsche, J ^b   Riedel, O ^b  

^a Maingau Hospital   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c CHEMNITZ UNIVERSITY OF TECHNOLOGY   (Germany)

^d SOUTHERN METHODIST UNIVERSITY   (United States)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

Asthma; Asthma control; Quality of life; Severe allergic asthma

Indexed keywords

ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OMALIZUMAB; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; RESPIRATORY CARE; SELF REPORT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; GERMANY; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; RESPIRATORY THERAPY; SPECIALIZATION; YOUNG ADULT;

EID: 80051735040     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.606805     Document Type: Article

References (51)

1. Anderson HR. Prevalence of asthma. Brit Med J 2005;330:1037-1038 (Pubitemid 40646549)
2. Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. Eur Respir J 2004;23:723-729 (Pubitemid 38618143)
3. Arnlind MH, Nokela M, Rehnberg C, et al. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care. J Asthma 2006;43:585-591 (Pubitemid 44581252)
4. Jansson S-A, Ronmark E, Forsberg B, et al. The economic consequences of asthma among adults in Sweden. Respir Med 2007;101:2263-2270 (Pubitemid 47471410)
5. Keller MB, Lowenstein SR. Epidemiology of asthma. Semin Respir Crit Care Med 2002;23:317-329 (Pubitemid 34971387)
6. Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: The global Asthma Insights and Reality surveys. J Allergy Clin Immun 2004;114:40-7 (Pubitemid 39022491)
7. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802-807 (Pubitemid 32049363)
8. Vermeire PA, Rabe KF, Soriano JB, et al. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142-149 (Pubitemid 35023683)
9. Global Initiative for Asthma (GINA). The Global Strategy for Asthma Management and Prevention, 2007. Available at: http://www.ginaasthma. org/Guidelines/Guidelines-resources.html [Last accessed 2011]
10. Chinn S, Jarvis D, Burney P, et al. Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health Survey. Thorax 2004;59:646-651 (Pubitemid 39061525)
11. Hermann-Kunz E, Allergic diseases in Germany. Bundesgesundheitsbl- Gesundheitsforsch-Gesundheitsschutz 2000;43:400-406
12. Beasley R. Unmet need in inadequately controlled asthma. Respirology 2007; 12:S18-S21 (Pubitemid 47621936)
13. Gaga M, Papageorgioou N, Karydi P, et al. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire. Clin Exp Allergy 2005;35:954-959 (Pubitemid 41032546)
14. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998;12:1209-1218 (Pubitemid 28545638)
15. Busse WW, Banks-Schlegel S, Wenzel S. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033-1042 (Pubitemid 32006254)
16. Buhl R, Berdel D, Criee C, et al. Guidelines for diagnosis and treatment of asthma patients. German Airway League and German Respiratory Society. Pneumonologie 2006;60:139-183
17. Gibson PG, Simpson JL. The European Network For Understanding Mechanisms Of Severe Asthma study. Eur Respir J 2004;23:492-495
18. Niven R, Chung KF, Panahloo Z, et al. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Respir Med 2008;102:1371-1378
19. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care 2004;170:836-844 (Pubitemid 39346477)
20. Busse WW, Wolfe J, Storms W, et al. Fluticasone propionate compared with zafirkulast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial. J Fam Pract 2001;50:595-602 (Pubitemid 32634099)
21. Nathan RA, Bleecker E, Kalberg C. A comparison of short-term treatment with inhaled fluticasone proprionate and zafirkulast for patients with persistent asthma. Am J Med 2001;111:195-202 (Pubitemid 32786947)
22. Wittchen HU, Kardos P, Mü hlig S, et al. The prevalence of severe allergic asthma in routine care-results from a nationwide epidemiological study. MMW submitted
23. Wittchen HU, Mü hlig S, Klotsche J, et al. Omalizumab vs. a matched 'treatment as usual' control group in routine care: a naturalistic 6-8 months followup of 106 patients with allergic asthma. Int Arch Allergy Immunol, submitted
24. Bundesä rztekammer (BÄ K). Kassenä rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Nationale Versorgungsleitlinie Asthma, 2nd Edn, 2009
25. Klotsche J, Leistner D, Pieper L, et al. The DETECT Adherence Score-structure and psychometric exploration of a novel approach to measure adherence to drug and non-drug interventions in primary care. Int J Method Psych 2011;20:82-92
26. Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549-556 (Pubitemid 43340217)
27. Ritz T, Steptoe A, Bobb C, et al. The asthma trigger inventory: validation of a questionnaire for perceived triggers of asthma. Psychosom Med 2006; 68:956-965 (Pubitemid 44808722)
28. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment in health related quality-of-life in asthma-development of a questionnaire for use in clinical-trials. Thorax 1992;47:76-83
29. Greiner W, Weijnen T, Nieuvenhuizen M, et al. A European EQ-5D VAS valuation set. In: Brooks R, Rabin R, de Charro F (eds). The Measurement and Valuation of Health Status Using EQ-5D-A European Perspective. Dortrecht: Kluwer, 2003:103-142
30. Wittchen H-U, Kessler RC,Ü stü n TB. Properties of the Composite International Diagnostic Interview (CIDI) for measuring mental health outcome. In: Tansella M, Thornicroft G (eds). Mental Health Outcome Measures. London: Gaskell, 2001:212-227
31. Wittchen H-U, Glaesmer H, Mä rz W, et al. Cardiovascular risk factors in primary care patients: methods and baseline prevalence. Results from the DETECT Program. Curr Med Res Opin 2005;21:619-629 (Pubitemid 40676115)
32. Royall RM. Model robust confidence intervals using maximum likelihood estimators. Int Stat Rev 1986;54:221-226
33. Brown SB, Vigil L, Khan DA, et al. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biol Psychiat 2005;58:865-870 (Pubitemid 41790714)
34. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease specific quality-of-life questionnaire. J Clin Epidemiol 1994;47:81-7 (Pubitemid 24034293)
35. Greenblatt M, Galpin JS, Hill C, et al. Comparison of doctor and patient assessments of asthma control. Respir Med 2010;104:356-361
36. Kendrick AH, Higgins CM, Whitfield MJ, et al. Accuracy of perception of severity of asthma: patients treated in general practice. Br Med J 1993; 307:422-424 (Pubitemid 23227471)
37. Priel B, Heimer D, Rabinowitz B, et al. Perceptions of asthma severity: the role of negative affectivity. J Asthma 1994;31:479-484
38. Dahme B, Richter R, Maß R. Interoception of respiratory resistance in asthmatic patients. Biol Psychology 1996;42:215-229 (Pubitemid 26011874)
39. Massasso DH, Salome CM, King GG, et al. Perception of bronchodilatation in subjects with asthma and smokers with airflow limitation. Respirology 1999;4:117-124 (Pubitemid 29268709)
40. Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near fatal and fatal asthma in relation to the perception of dyspnea. Chest 2002; 121:329-333 (Pubitemid 34132965)
41. Bogaerts K, Notebaert K, van Diest I, et al. Accuracy of symptom perception in different affective contexts. J Psychosom Res 2005;58:537-543 (Pubitemid 41206850)
42. Rietveld S, Van Beest, I. Prins PJM. The relationship between specific anxiety syndromes and somatic symptoms in adolescents with asthma and other chronic diseases. J Asthma 2005;42:725-730 (Pubitemid 41759186)
43. Yawn BP, Molen T, Humbert M. Asthma management: are GINA guidelines appropriate for daily clinical practice? Prim Care Respir J 2005;14: 294-302 (Pubitemid 41728069)
44. Katon W, Lozano P, Russo J, et al. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolescent Health 2007;41:455-463 (Pubitemid 47562796)
45. Kullowatz A, Kanniess F, Dahme B, et al. Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med 2007;101:638-644 (Pubitemid 46196312)
46. Oga T, Nishimura K, Sato S. Analysis of longitudinal changes in the psychological status of patients with asthma. Respir Med 2007;101:2133-2138 (Pubitemid 47324239)
47. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes-a meta-analysis. Med Care 2002;40:794-811
48. Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/ fluticasone. Respir Med 2007;101:2437-2446 (Pubitemid 350010579)
49. Mawhinney H, Spector S, Kinsman A, et al. Compliance in clinical trials of two nonbronchodilator, anti-asthma medications. Ann Allergy 1991;66:294-299
50. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559-1564
51. Corsico AG, Cazzoletti L, de Marco R, et al. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med 2007;101:1363-7 (Pubitemid 46667680)